Back to Search
THOMAS RICH, MD
MD
Anesthesiology Physician
NPI: 1235158338Individual
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
Research & Publications (20)
Preoperative chemoradiotherapy for esophageal cancer: impressive downstaging with acceptable toxicity.
PMID 19262704·Gastrointest Cancer Res·2007
8-other
Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis.
PMID 17500504·J Support Oncol·2007
6-review
Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer.
PMID 15755997·Clin Cancer Res·2005
8-other
Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.
PMID 15169811·J Clin Oncol·2004
6-review
Mutations throughout the S6 region of the hKv1.5 channel alter the stability of the activation gate.
PMID 11742809·Am J Physiol Cell Physiol·2002
7-preclinical
Camptothecin dose, schedule, and timing of administration for clinical radiation sensitization.
PMID 11193916·Ann N Y Acad Sci·2000
7-preclinical
PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool.
PMID 19261859·Proc Natl Acad Sci U S A·2009
7-preclinical
Optimizing standard patient management through order sets - impact on care (blood cultures).
PMID 19380981·Stud Health Technol Inform·2009
8-other
Receptor reserve reflects differential intrinsic efficacy associated with opioid diastereomers.
PMID 19463265·Pharmacol Biochem Behav·2009
7-preclinical
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
PMID 19017755·J Clin Endocrinol Metab·2009
5-case
PML: a tumor suppressor that regulates cell fate in mammary gland.
PMID 19652541·Cell Cycle·2009
6-review
Development of a high-throughput assay for monitoring cAMP levels in cardiac ventricular myocytes.
PMID 19247193·J Cardiovasc Pharmacol·2009
7-preclinical
Adenovirus type 5 E4 Orf3 protein targets promyelocytic leukaemia (PML) protein nuclear domains for disruption via a sequence in PML isoform II that is predicted as a protein interaction site by bioinformatic analysis.
PMID 19088278·J Gen Virol·2009
8-other
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.
PMID 19139424·J Clin Oncol·2009
4-observational
Treatment of primary liver tumors with Yttrium-90 microspheres (TheraSphere) in high risk patients: analysis of survival and toxicities.
PMID 19166244·Technol Cancer Res Treat·2009
8-other
Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.
PMID 19642177·Cancer·2009
8-other
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.
PMID 19636002·J Clin Oncol·2009
3-trial
Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma.
PMID 19259306·Gastrointest Cancer Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 GRESHAM DR
NORFOLK, VA 23507 - Phone
- (757) 668-3871
Quick Facts
- NPI
- 1235158338
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile